When Josh Fleig, Louisiana’s chief innovation officer, learned his state had set aside $20 million a year, for five years, to invest in startup rural health companies, his reaction was not surprising: “Wow!”
In rural America, where people are often reported to be sicker with poor access to healthcare, the cash influx is a relief. In the economic development space where Fleig operates, it’s an opportunity.
“Look, that’s a lot of money for what we do,” said Fleig, whose state-funded economic development office invests in corporate launches, ranging from software startups to shipbuilders.
Louisiana and a handful of other states set aside money from their share of the $50 billion federal Rural Health Transformation Program to quickly invest in new technologies, mirroring private industry moves. Lawmakers added the rural health program to offset more than $900 billion in reduced Medicaid spending expected over 10 years from Republicans’ sweeping 2025 tax and spending law.
But rather than filling the budget hole, the rural program’s assignment is to find new approaches for revitalizing rural communities where doctors are in short supply and hospitals have been downsizing and closing for decades. The federal government doled out the first-year rural health program awards to states this year, with pots ranging from $147 million in New Jersey to $281 million in Texas.
Modernizing technology infrastructure is a key pillar of the federal rural health program, and the catalyst money epitomizes the administration’s strategy to move fast and experiment with untested technology — much like the “move fast and break things” mantra during the heyday of Silicon Valley.
Instead of breaking things, though, the goal is to “move fast, fast-fail, innovate quickly, and move to sustainability,” said Aaron Bujnowski, a managing director with the healthcare industry group at the consultancy Alvarez & Marsal. “This is a transformation that is still meant to serve the people.”
Rigorous Rules and Tight Deadlines
Beyond Louisiana, Timothy Foster, a spokesperson for the Centers for Medicare & Medicaid Services, confirmed that Delaware, Georgia, Massachusetts, Nebraska, South Carolina, Virginia, and West Virginia are also creating rural health tech catalyst funds.
Every year, states must compete for rural funding in the five-year federal program. Federal regulators will take money away from states that do not meet the goals promised in their applications, including whether they designated money to companies for tech innovations.
CMS, which is overseeing the program, released a seven-step guidance document for states to follow when creating the tech catalyst operations. No more than 10% of each state’s award can be spent on a rural tech catalyst fund.
States’ initial annual progress reports for the rural fund were due at the end of August. CMS has declined to publicly post those reports; it plans to publish an annual report on state progress. States must show that first-year funds will be obligated — but not necessarily spent — by Oct. 30, according to the CMS guidance document.
Daniel X. O’Neil, a technology consultant who advocates for open data and open government, created a state tracker and parsed the original state applications to find dozens that mention catalyst awards and technology funds.
O’Neil said he is “looking forward to the clawbacks and the craziness of October because, you know, that’s serious stuff.”
For the rural health catalyst funds, CMS requires states to submit the list of finalists “at least 15 business days” before announcing winners, along with “sufficient information” for the agency to “assess each proposed project,” according to the guidance document.
The document outlines intellectual property and federal rights but does not provide guidance or standards for patient rights or protections. CMS spokesperson Foster stated in an email that the technology investments must comply with federal “privacy, security, interoperability, and patient safety” requirements.
Protecting Patients
Maya Sandalow, director of the health program at the Bipartisan Policy Center and one of the leading analysts watching the rural fund, said the catalyst funds are “public dollars” and has called for more transparency in the overall rural health program. The center is a nonprofit think tank in Washington, D.C.
Accurate and timely reporting must be done to ensure “the necessary guardrails are in place” to protect patients, she said, adding that the innovation needs to be “tested in a way that’s safe for the patients that they are going to be used on.”
To apply, startups must be less than 10 years old and have raised less than $50 million in early funding. Companies that win a portion of state catalyst funds must meet predetermined milestones before being paid — and federal officials will make “targeted reviews as needed,” according to the guidance document.
Louisiana officials announced the state’s tech catalyst fund with an event in rural Natchitoches, known as the filming location of the 1989 film Steel Magnolias. The fund quickly drew more than 200 companies competing for between $250,000 and $3 million in seed money.
Tiny startup Greens Health was invited to the event. The 2-year-old company analyzes Medicare claims to identify patients with chronic diseases, such as diabetes, and works with local home health nurses and senior facilities to improve care.
“We’ve been looking for a way to launch in Louisiana,” said Kehlin Swain, co-founder and chief executive of Greens Health. The company serves about 100 patients across Texas, Alabama, and Florida and hopes to get a $250,000 investment from Louisiana.
Louisiana’s Fleig said his state is “at a really interesting turning point.” The state secured $208.4 million for the first year of the rural health program and quickly created its catalyst fund using the state’s already established innovation department.
At the same time, nearly 1.1 million people live in Louisiana’s rural parishes and the state ranks as the “least healthy” in the nation, according to its own application. State rates of diabetes, obesity, and cardiovascular disease are among the highest in the nation.
Fleig believes Louisiana is an ideal place to test technology solutions. So, while Silicon Valley has “not needed much of what Louisiana has had to offer” for much of its existence, it does now, he said.
Caret Health is one of those companies. Co-founders Riya Pulicharam, who is a physician-researcher, and Kevin Zhao, an engineer, met in Silicon Valley. Together, they created a technology platform that identifies patients who need help getting to their appointments, having scans done, or picking up prescriptions. That technology flags a human, who then contacts the patient with a call or text.
Zhao said Caret had successful pilots at large health systems, but those places also had other vendors and “it was a pretty big uphill battle” to get in and scale. Then, in 2024, the company began paying attention to rural places.
“There wasn’t a lot of existing infrastructure. And that was really good for us because we were able to come in very quickly,” Zhao said. “A lot of the hospitals really needed this kind of service.”
Fast-forward to 2026: Caret Health is about 4 years old and has contracted with about 60 hospitals in 16 states. Pulicharam and Zhao hope to win $3 million to expand into Louisiana.
Louisiana’s Fleig said the state will take an equity stake in each company it invests in. “The dream” is that selected startup companies will also help the state make money to reinvest. If some companies fail — or fail fast — that’s to be expected, but the state should still make money because of “the law of averages,” he said.
“If we are good, we’ll make more money than we spent,” Fleig said. “Either way, it’s going to go back into improving healthcare outcomes.”
Rural Tech-Catalyst Funds: Fast-Moving, High-Pressure
First-year progress reports were due at the end of August. Using the annual report, federal officials will recalculate and potentially claw back money from underperforming states, according to reporting requirements created by the Centers for Medicare & Medicaid Services, which oversees the program.
States will be scored on a multitude of initiatives and plans, plus whether they earmark their first-year spending by Oct. 30. Year 2 funding will be determined by the end of October.
Facts Only
* The federal Rural Health Transformation Program provides $50 billion to states.
* Louisiana, Delaware, Georgia, Massachusetts, Nebraska, South Carolina, Virginia, and West Virginia are creating rural health tech catalyst funds.
* Catalyst funds are limited to 10% of each state's total award.
* State awards for the first year range from $147 million in New Jersey to $281 million in Texas.
* Louisiana received $208.4 million for the first year and allocated $20 million annually for five years to its catalyst fund.
* Eligible startups must be under 10 years old and have raised less than $50 million.
* State catalyst fund investments range from $250,000 to $3 million per company.
* Louisiana takes an equity stake in companies it invests in.
* CMS requires states to submit finalist lists 15 business days before announcing winners.
* First-year funds must be obligated by October 30.
* Progress reports were due at the end of August.
* CMS may claw back money from states that fail to meet goals.
Executive Summary
Federal funding via the Rural Health Transformation Program is driving a shift toward venture-style investing in rural healthcare. Several states are utilizing a portion of these funds to create "catalyst funds" designed to seed early-stage health tech startups. The objective is to modernize infrastructure and address chronic shortages of doctors and hospitals in rural areas, employing a "fast-fail" innovation model similar to Silicon Valley.
While the program offers a potential lifeline for rural communities and an entry point for startups, it introduces significant regulatory and ethical tensions. Federal regulators emphasize strict deadlines and performance-based funding, including the possibility of clawbacks for underperforming states. Simultaneously, critics express concern over the lack of explicit federal guidance regarding patient rights and protections, noting that the focus on intellectual property and speed may overshadow patient safety. The long-term success of the program remains uncertain, depending on whether these equity-based investments can scale effectively to improve health outcomes in the nation's least healthy regions.
Full Take
The strongest version of this narrative is that the government is evolving its role from a mere provider of grants to a strategic investor, leveraging private-sector agility to solve systemic failures in rural healthcare that traditional bureaucracy has failed to fix for decades.
However, there is a profound paradigm shift occurring here: the "financialization" of public health. By applying a "move fast and break things" ethos to healthcare, the state is treating patient outcomes as a byproduct of a venture capital portfolio. The assumption is that the "law of averages" will protect public funds and that equity stakes will create a sustainable loop of reinvestment. This echoes the broader trend of neoliberal governance, where public services are managed through market-driven mechanisms rather than direct public administration.
The second-order consequence is the potential for "innovation theater." When states are under extreme pressure to "obligate" funds by a deadline to avoid clawbacks, the incentive shifts from finding the *best* solution to finding *any* solution that fits the eligibility criteria. This creates a risk where patient safety becomes a secondary compliance checkbox rather than the primary design goal.
Patterns detected: none
Root Cause: The narrative is driven by the belief that the efficiency of Silicon Valley’s capital deployment is a universal solvent for institutional decay.
Implications: This model benefits agile tech founders and state innovation officers, while the risks—both financial and clinical—are borne by the rural populations already suffering from the highest rates of chronic disease.
Bridge Questions:
1. If a state-funded startup fails "fast," what happens to the patients who were integrated into its untested pilot programs?
2. Does an equity stake in a private company align the state's interests with public health, or does it create a conflict of interest regarding pricing and access?
Counterstrike Scan: A coordinated campaign would likely frame this as a "miracle cure" for the rural divide to distract from the Medicaid spending cuts mentioned in the text. The actual content remains neutral by including the Bipartisan Policy Center's warnings and the specific mention of the 2025 tax law.
